Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Fishawack continues to build best-in-class service offering with Dudnyk acquisition

Fishawack, a leading independent healthcare communications specialist, announced the acquisition of Philadelphia-based healthcare communications agency Dudnyk.

Read More »

Pfizer buys stake in French gene therapy firm Vivet

Pfizer acquired a 15 percent stake in Vivet Therapeutics as well as an exclusive option to fully acquire the business, a deal that will give the New York-based pharma giant access to the French company’s experimental gene therapy for a rare genetic disorder.

Read More »

EVERSANA unveils new global market access research solutions from Health Strategies Insights

EVERSANA, the leading independent provider of global services to the life science industry, introduced a new suite of global market access solutions from Health Strategies Insights to help biopharmaceutical manufacturers understand the latest global trends in access, payment, distribution and administration.

Read More »

The Inception Company Partners with WEGO Health to Launch a Virtual Patient Collaboration Platform via Pando

The Inception Company, a technology-driven production company, and WEGO Health, the premiere network of patient opinion leaders and health influencers, announced the launch of “Patient Co-Lab.”

Read More »

Women’s History Month: Top Influential Women in Biopharma

March is National Women’s Month, and BioSpace recognized these 10 women as being especially influential in the biopharma industry.

Read More »

Healthline Invigorates its Board by Adding Proven Brand Builder with Deep Product, Marketing and Media Expertise

Healthline Media Inc. announced the addition of a new member to the company’s board of directors with a track record of creating blockbuster brands: Kira Wampler.

Read More »

Alcon Acquires PowerVision for $285 Million

Alcon, the eye care division of Novartis, acquired fluid-based intraocular lens maker PowerVision Inc. for $285 million.

Read More »

U.S. court rejects Alvogen’s patent challenge for Celgene’s cancer drug

The U.S. patent office rejected a filing by Alvogen Pine Brook for a review challenging patents on Celgene’s blockbuster myeloma drug Revlimid.

Read More »

Novartis generics boss quits amid conjecture over business’s future

Novartis’ generics chief stepped down after the Swiss drugmaker sold parts of the business and initiated an 18-month revamp, fueling speculation about an eventual spin-off or sale.

Read More »

California jury awards $29 million to woman with cancer who used J&J talc

A California jury awarded $29 million to a woman who said abestos in Johnson & Johnson’s talcum-powder-based products caused her cancer.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom